Google Play icon

Researchers clarify role of genetic risk factor in Alzheimer’s

Share
Posted June 1, 2015

ientists at the Keck School of Medicine of USC have discovered that a protein known as PICALM regulates removal of toxic plaques from the brain, which could be a potential therapeutic target for the treatment of Alzheimer’s disease.

Snapshot of a neurovascular unit, consisting of neurons (pink), astrocytes (blue), resident microglia (green), a penetrating arteriole and capillaries (white) (Photo/Zlokovic Lab)

Snapshot of a neurovascular unit, consisting of neurons (pink), astrocytes (blue), resident microglia (green), a penetrating arteriole and capillaries (white) (Photo/Zlokovic Lab)

In a study that appeared in a recent edition of Nature Neuroscience, researchers identify this new role for PICALM, which is a known genetic risk factor for Alzheimer’s disease.

Alzheimer’s is the most common type of dementia, characterized by the loss of memory and other mental abilities linked to an accumulation of amyloid-beta and other toxic compounds in the brain.

The study found that a deficiency in PICALM in cerebral blood vessels and in PICALM-related gene variants associated with increased risk for Alzheimer’s, disable amyloid-beta from being cleared out of the brain across a region known as the blood-brain barrier.

“There have been many new genes discovered to be associated with Alzheimer’s disease, but the biology of these genes are poorly understood,” said the study’s principal investigator Berislav Zlokovic, director of theZilkha Neurogenetic Institute and holder of the Mary Hayley and Selim Zilkha chair for Alzheimer’s Disease research at the Keck School of Medicine. “Our new study shows that a deficiency in PICALM in blood vessels and its variants associated with increased risk for the disease inactivate amyloid-beta clearance from the brain, leading to its accumulation and cognitive impairment. This new study provides fundamental new information about PICALM and brings to light novel potential therapeutic targets for increasing amyloid-beta clearance in Alzheimer’s disease.”

Autopsies from Alzheimer’s patients and recent research in experimental models have shown the importance of brain blood vessels in the disease’s initiation and progression.

Molecular mechanisms

For more than two decades, Zlokovic and his research team have studied the cellular and molecular mechanisms of brain blood vessels that maintain normal cognition with hopes of developing new treatments for Alzheimer’s and other neurodegenerative diseases. One focus of their lab at the Zilkha Neurogenetic Institute is on PICALM, or phosphatidylinositol binding clathrin assembly protein, which in humans is encoded by the PICALM gene.

By performing a neuropathological study in humans with Alzheimer’s and using transgenic animals to model the disease, the group found that low levels of PICALM in brain endothelial cells lead to amyloid-beta accumulation in the brain. Genetic variants associated with the PICALM gene have been shown to increase the risk of Alzheimer’s disease.

The researchers also generated human endothelial cells from induced pluripotent stem cells to examine the consequences of a known PICALM variant associated with increased risk for Alzheimer’s; they found that this genetic alteration disrupted amyloid-beta clearance by cerebral blood vessels.

These new findings have prompted Zlokovic to address new questions about the role of PICALM in Alzheimer’s. Future studies will explore how genetic flaws in the PICALM gene influence its expression levels and clearance function at the blood-brain barrier and the general health of cerebral blood vessels. The team also will work on developing therapeutic strategies, including gene therapy, and screening for new drugs to overcome PICALM deficiency.

Source: USC

Featured news from related categories:

Technology Org App
Google Play icon
86,007 science & technology articles

Most Popular Articles

  1. Universe is a Sphere and Not Flat After All According to a New Research (November 7, 2019)
  2. NASA Scientists Confirm Water Vapor on Europa (November 19, 2019)
  3. This Artificial Leaf Turns Atmospheric Carbon Dioxide Into Fuel (November 8, 2019)
  4. How Do We Colonize Ceres? (November 21, 2019)
  5. Scientists have Discovered a Place on Earth with no Biological Life (November 25, 2019)

Follow us

Facebook   Twitter   Pinterest   Tumblr   RSS   Newsletter via Email